Dublin, Dec. 19, 2016 -- Research and Markets has announced the addition of the "Anti-Aging Products - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Anti-Aging Products in US$ by the following Product Segments:
- Anti-Aging Products for Health Maintenance (Pharmaceuticals for Age-Related Health Conditions, & Supplements for Age-Related Health Conditions)
- Anti-Aging Products for Appearance Enhancement (Skin Care, Hair Care, & Others).
The report profiles 326 companies including many key and niche players such as
- Allergan Plc (Ireland)
- ARK Skincare (UK)
- Avon Products Inc. (USA)
- Beiersdorf (Germany)
- Bayer HealthCare Pharmaceuticals (Germany)
- Biomod Concepts, Inc. (Canada)
- Chanel SA (France)
- Christian Dior S.A. (France)
- Clarins (France)
- Elizabeth Arden Inc. (USA)
- Ella Bache (France)
- Estee Lauder Inc. (USA)
- Clinique Laboratories, LLC. (USA)
- GlaxoSmithKline Plc (UK)
- Henkel KGaA (Germany)
- Jan Marini Skin Research Inc. (USA)
- Johnson & Johnson (USA)
- Neutrogena Corporation (USA)
- L'Oreal SA (France)
- LR Health & Beauty Systems (Greece)
- Merck & Company Incorporated (USA)
- Navarre Wellness (USA)
- NeoStrata Company, Inc. (USA)
- Procter & Gamble (USA)
- Pfizer Incorporated (USA)
- Revlon Inc.
- Shiseido Co. Ltd. (Japan)
- Unilever PLC (UK)
- Valeant Pharmaceuticals International
Key Topics Covered:
1. Industry Overview
2. Competition
3. Market Trends And Drivers
4. Anti-Aging Appearance And Health Products: Innovations & Advancements
5. Key Issues Confronting The Market
6. Regulatory Framework
7. Product Overview
8. Product Innovations/Introductions
9. Recent Industry Activity
10. Focus On Select Global Players
11. Global Market Perspective
Total Companies Profiled: 326 (including Divisions/Subsidiaries 355)
- The United States (123)
- Canada (10)
- Japan (5)
- Europe (168)
- - France (40)
- - Germany (25)
- - The United Kingdom (17)
- - Italy (19)
- - Spain (4)
- - Rest of Europe (63)
- Asia-Pacific (Excluding Japan) (32)
- Latin America (1)
- Africa (4)
- Middle East (13)
For more information about this report visit http://www.researchandmarkets.com/research/gsq7kr/antiaging
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Personal Care Products , Skin Care Products


U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 



